PA
LILAK icon

PharVision Advisers’s Liberty Latin America Class C LILAK Stock Holding History

PharVision Advisers’s Portfolio LILAK Stock Details LILAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
+14,130
New +$102K 2.08% 12
2026
Q1 		– Sell
-32,568
Closed -$221K – 402
2025
Q4 		$221K Buy
+32,568
New +$244K 0.11% 476

Other funds holding LILAK

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
QCI
Quaker Capital Investments Mount Lebanon, Pennsylvania $366M AUM 35.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $333M AUM 102.25% 1-Year Est. Return

PharVision Advisers's LILAK Position: Q2 2026 in Review

PharVision Advisers opened a new position in Liberty Latin America Class C (LILAK) in Q2 2026: 14,130 shares worth $110K. The stake represents 2.08% of the portfolio and ranks #12 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in LILAK as recently as Q4 2025.

PharVision Advisers first reported a position in LILAK in Q4 2025 and has held it in 2 quarters since. The position peaked at $221K in Q4 2025. 225 funds tracked by Wall St. Rank hold LILAK as of Q2 2026.

  • PharVision Advisers held 14,130 shares of Liberty Latin America Class C worth $110K as of Q2 2026.
  • Liberty Latin America Class C was a new PharVision Advisers position in Q2 2026.
  • Liberty Latin America Class C made up 2.08% of PharVision Advisers's portfolio in Q2 2026, its #12 holding.
  • PharVision Advisers first reported a position in Liberty Latin America Class C in Q4 2025 and has held it in 2 quarters since.
  • PharVision Advisers's Liberty Latin America Class C position peaked at $221K in Q4 2025.
  • 225 funds tracked by Wall St. Rank held Liberty Latin America Class C as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.